Trademarkia Logo

Canada

C$
ORBITAL THERAPEUTICS
FORMALIZED

on 12 Feb 2025

Last Applicant/ Owned by

Orbital Therapeutics, Inc.

100 Binney Street, Floor 4Cambridge MA 02142

US

Serial Number

2379587 filed on 14th Aug 2024

ORBITAL THERAPEUTICS

Trademark usage description

pharmaceutical preparations for the prevention and treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders Read More

Vienna Information


1 . 5 . 24

SaturnSaturne

24 . 17 . 1

Punctuation marksSignes de ponctuation

24 . 17 . 2

DotsPoints

25 . 7 . 1

Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés

25 . 7 . 7

Surfaces or backgrounds covered with dotsSurfaces ou fonds couverts de points

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; protein-based therapeutics for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; therapeutic and preventative vaccines; medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of diseases and disorders; RNA-based therapeutics; therapeutic agents for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders.


Classification kind code

12

Class [042]
Research and development in the biotechnology field; consulting services in the fields of biotechnology and genetic science; development of new technology for others in the fields of genomics and biotechnology; providing laboratory research services in the field of gene expression or RNA-based therapeutics; testing, inspection, research, or development of chemical and biotechnology preparations; scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics; design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids; providing information on the subject of scientific and medical research in the fields of biotechnology, biologics, biosimilars, pharmaceuticals, vaccines, and therapeutics related to genetic science, genomics, gene expression, protein-encoding nucleic acids or polypeptide-encoding nucleic acids.


Classification kind code

12

Mark Details


Serial Number

2379587

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 13th Feb 2025
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 12th Feb 2025
Created
Submitted for opposition 31
on 12th Feb 2025
Formalized
Submitted for opposition 228
on 14th Aug 2024
International Registration
Submitted for opposition 30
on 14th Aug 2024
Filed